DNA-isophosphoramide mustard adducts (DNA-IPM adducts) (DNA-IPM adducts)

DNA-isophosphoramide mustard adducts represent the critical molecular lesions formed by the interaction of the active metabolite of ifosfamide with cellular DNA (StatPearls, 2023). Ifosfamide is a nitrogen mustard prodrug that undergoes hepatic activation via cytochrome P450 enzymes (CYP3A4 and CYP2B6) to produce isophosphoramide mustard (IPM), the primary alkylating species (PubChem, CID 3690). IPM acts as a bifunctional alkylator, covalently binding to DNA bases—most frequently at the N7 position of guanine—to form monoadducts and, more significantly, interstrand cross-links (PubMed, PMID 15506959). These cross-links physically impede the progression of DNA polymerase and RNA polymerase, thereby inhibiting DNA replication and transcription (NIH, National Cancer Institute). The accumulation of these adducts triggers DNA damage response pathways, leading to cell cycle arrest and the induction of apoptosis in malignant cells. While central to the therapeutic efficacy of ifosfamide in treating sarcomas, lymphomas, and testicular cancer, the formation of these adducts in healthy tissues is associated with dose-limiting toxicities, including myelosuppression and potential mutagenicity leading to secondary malignancies (PubMed, PMID 10863244).

Other names

DNA-ifosfamide mustard adductsIsophosphoramide mustard-DNA cross-linksN7-guanine ifosfamide adductsIfosfamide-DNA adducts

Ifosfamide is metabolically activated to isophosphoramide mustard, which functions as a bifunctional alkylating agent. It forms covalent bonds with DNA, specifically creating N7-guanine adducts and interstrand cross-links. These lesions disrupt the DNA template, preventing replication and transcription, which leads to cell death in rapidly dividing cells (StatPearls, 2023; PubChem, CID 3690).